STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER

596047 Disclosed herein is an orally deliverable pharmaceutical composition comprising a Bcl-2 family protein inhibitory compound, e.g., ABT-263, a heavier-chalcogen antioxidant and a substantially non-aqueous lipid carrier, wherein said compound and said antioxidant are in solution in the carrier....

Full description

Saved in:
Bibliographic Details
Main Authors SANZGIRI, YESHWANT, FICKES, MICHAEL, HEEMSTRA, KATHERINE, FISCHER, CRISTINA, HAIGHT, ANTHONY R, SCHMITT, ERIC, ZHANG, GEOFF, TONG, PING, ZHOU, DELIANG, CATRON, NATHANIEL
Format Patent
LanguageEnglish
Published 29.11.2013
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract 596047 Disclosed herein is an orally deliverable pharmaceutical composition comprising a Bcl-2 family protein inhibitory compound, e.g., ABT-263, a heavier-chalcogen antioxidant and a substantially non-aqueous lipid carrier, wherein said compound and said antioxidant are in solution in the carrier. The composition is suitable for oral administration to a subject in need thereof for treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.
AbstractList 596047 Disclosed herein is an orally deliverable pharmaceutical composition comprising a Bcl-2 family protein inhibitory compound, e.g., ABT-263, a heavier-chalcogen antioxidant and a substantially non-aqueous lipid carrier, wherein said compound and said antioxidant are in solution in the carrier. The composition is suitable for oral administration to a subject in need thereof for treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.
Author TONG, PING
SCHMITT, ERIC
HAIGHT, ANTHONY R
HEEMSTRA, KATHERINE
CATRON, NATHANIEL
ZHOU, DELIANG
FICKES, MICHAEL
FISCHER, CRISTINA
SANZGIRI, YESHWANT
ZHANG, GEOFF
Author_xml – fullname: SANZGIRI, YESHWANT
– fullname: FICKES, MICHAEL
– fullname: HEEMSTRA, KATHERINE
– fullname: FISCHER, CRISTINA
– fullname: HAIGHT, ANTHONY R
– fullname: SCHMITT, ERIC
– fullname: ZHANG, GEOFF
– fullname: TONG, PING
– fullname: ZHOU, DELIANG
– fullname: CATRON, NATHANIEL
BookMark eNrjYmDJy89L5WQwCg5xdPL08YxydVHw8QzwdFFw8w_yDfVxDPH091Pwd1NwDPAPCPEP9gxWCAjy9_UPcQ3iYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxflGmlmYGJuaOxgQVAAC4cSf5
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID NZ596047A
GroupedDBID EVB
ID FETCH-epo_espacenet_NZ596047A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:52:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_NZ596047A3
Notes Application Number: NZ20100596047
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131129&DB=EPODOC&CC=NZ&NR=596047A
ParticipantIDs epo_espacenet_NZ596047A
PublicationCentury 2000
PublicationDate 20131129
PublicationDateYYYYMMDD 2013-11-29
PublicationDate_xml – month: 11
  year: 2013
  text: 20131129
  day: 29
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies ABBVIE INC
RelatedCompanies_xml – name: ABBVIE INC
Score 2.9110587
Snippet 596047 Disclosed herein is an orally deliverable pharmaceutical composition comprising a Bcl-2 family protein inhibitory compound, e.g., ABT-263, a...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131129&DB=EPODOC&locale=&CC=NZ&NR=596047A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQMANxvsx9YB6qyhpS-mhQn1qRWtTrR2adpmSpUNcxsSK-Ps4VQdcdomiRHISR479ObEDcIcaziEW7sDcdGzNZMzQOCdYVIIx3WG6IWSgcJo9Dsbmy8SadOBtEwvT5An9bpIjokTNUd7r5rxe_TmxwuZt5fqev2PTx3NcuqHaomOZOwYBdOi7UU5DGqhB4GZTNRu5lkxCYns7sIs2tC1FIXr1ZUjK6r8-iY9gL0dSy_oYOtWyBwfB5tu1Huyn7W03VlvBW58AKUrPT4bJNAoVxOJJqCB6S8fDxsOk0FjxcpqXtEgKJR_RlKKRegr9OCqDgYaDz36XOcum7SSNM-gi9q8uQNEXwnnghi44RyjDzCfU2JUtiEBWkoWpX8L5FiJXW3uu4VBySgbUEecGuvXnV3WLmrXm_YYrPxvVeoE
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT4MwEL_MaZxvOr8_Jg-GNyLyIeOBGD4DCpQMZhZeCB3M-DIXh_Hf90qY-rKXpmmTa3vN9e537V0B7lDD6ZKKOzBXdE1QylIWKJWwqKuyFPVSlCsWKBzFj_5UeZ6psx68bWJh2jyh321yRJSoOcp7057Xqz8nltO-rVzf03ds-njyMsPhO3TMcscggHYsw02IQ2zeto045-OJobIkJJq5A7toX4_ZVwfuq8VCUlb_9Yl3CHsJklo2R9Crl0MY2Jtv14awH3W33VjtBG99DFKamVYQBrnrcIjFA4dD9BZNw9bDxBGPMxOSZCQNUi6ZkIigkXoCI8_NbF_AwYvfZRZx3k1SPoU-Yv_6HDhxUekPVBYrShHKlMoYNXatVVKFrJQWingBZ1uIXG7tuYWBn0VhEQbxyxUcMK6x4DpJv4Z-8_lV36CWbeio5dAPAfF9cQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=STABILIZED+LIPID+FORMULATION+OF+APOPTOSIS+PROMOTER&rft.inventor=SANZGIRI%2C+YESHWANT&rft.inventor=FICKES%2C+MICHAEL&rft.inventor=HEEMSTRA%2C+KATHERINE&rft.inventor=FISCHER%2C+CRISTINA&rft.inventor=HAIGHT%2C+ANTHONY+R&rft.inventor=SCHMITT%2C+ERIC&rft.inventor=ZHANG%2C+GEOFF&rft.inventor=TONG%2C+PING&rft.inventor=ZHOU%2C+DELIANG&rft.inventor=CATRON%2C+NATHANIEL&rft.date=2013-11-29&rft.externalDBID=A&rft.externalDocID=NZ596047A